CD4 and neoplasm: But other, HLA class I-independent effector mechanisms might step in, such as CD4+ tumor-reactive T cells with direct effects on HLA class II-positive and indirect effects on HLA class II-negative tumors [45–47] as well as natural killer cells [48].